english

146 publications depuis le 01/01/2018

Adenis, A., Castan, F., Conroy, T., 2018. Consolidation chemotherapy after definite concurrent chemoradiation in patients with non-operable esophageal cancer: Is it useful? Radiother Oncol 129, 180–181. https://doi.org/10.1016/j.radonc.2017.12.018

 

Adenis, A., Lordick, F., 2018. Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer. JAMA Oncol 4, 887–888. https://doi.org/10.1001/jamaoncol.2018.0239

 

Amblard, I., Mercier, F., Bartlett, D.L., Ahrendt, S.A., Lee, K.W., Zeh, H.J., Levine, E.A., Baratti, D., Deraco, M., Piso, P., Morris, D.L., Rau, B., Tentes, A. a. K., Tuech, J.-J., Quenet, F., Akaishi, E., Pocard, M., Yonemura, Y., Lorimier, G., Delroeux, D., Villeneuve, L., Glehen, O., Passot, G., PSOGI and BIG RENAPE working groups, 2018. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups. Eur J Surg Oncol 44, 1378–1383. https://doi.org/10.1016/j.ejso.2018.04.023

 

André, T., Vernerey, D., Mineur, L., Bennouna, J., Desrame, J., Faroux, R., Fratte, S., Hug de Larauze, M., Paget-Bailly, S., Chibaudel, B., Bez, J., Dauba, J., Louvet, C., Lepere, C., Dupuis, O., Becouarn, Y., Mabro, M., Egreteau, J., Bouche, O., Deplanque, G., Ychou, M., Galais, M.P., Ghiringhelli, F., Dourthe, L.M., Bachet, J.-B., Khalil, A., Bonnetain, F., de Gramont, A., Taieb, J., for PRODIGE investigators, GERCOR, Fédération Française de Cancérologie Digestive, and UNICANCER, 2018. Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial. J. Clin. Oncol. 36, 1469–1477. https://doi.org/10.1200/JCO.2017.76.0355

 

Andrique, C., Morardet, L., Linares, L.K., Cissé, M.Y., Merle, C., Chibon, F., Provot, S., Haÿ, E., Ea, H.-K., Cohen-Solal, M., Modrowski, D., 2018. Calpain-6 controls the fate of sarcoma stem cells by promoting autophagy and preventing senescence. JCI Insight 3. https://doi.org/10.1172/jci.insight.121225

 

Antonia, S.J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K.H., de Wit, M., Cho, B.C., Bourhaba, M., Quantin, X., Tokito, T., Mekhail, T., Planchard, D., Kim, Y.-C., Karapetis, C.S., Hiret, S., Ostoros, G., Kubota, K., Gray, J.E., Paz-Ares, L., de Castro Carpeño, J., Faivre-Finn, C., Reck, M., Vansteenkiste, J., Spigel, D.R., Wadsworth, C., Melillo, G., Taboada, M., Dennis, P.A., Özgüro?lu, M., PACIFIC Investigators, 2018. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1809697

 

Arena, G., Cissé, M.Y., Pyrdziak, S., Chatre, L., Riscal, R., Fuentes, M., Arnold, J.J., Kastner, M., Gayte, L., Bertrand-Gaday, C., Nay, K., Angebault-Prouteau, C., Murray, K., Chabi, B., Koechlin-Ramonatxo, C., Orsetti, B., Vincent, C., Casas, F., Marine, J.-C., Etienne-Manneville, S., Bernex, F., Lombès, A., Cameron, C.E., Dubouchaud, H., Ricchetti, M., Linares, L.K., Le Cam, L., 2018. Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53. Mol. Cell 69, 594-609.e8. https://doi.org/10.1016/j.molcel.2018.01.023

 

Arena, G., Riscal, R., Linares, L.K., Le Cam, L., 2018b. MDM2 controls gene expression independently of p53 in both normal and cancer cells. Cell Death Differ. 25, 1533–1535. https://doi.org/10.1038/s41418-018-0156-x

 

Aristei, C., Kaidar-Person, O., Tagliaferri, L., Arenas, M., Coles, C.E., Offersen, B.V., Frezza, G., Leonardi, M.C., Valentini, V., Bourgier, C., Poortmans, P.M.P., 2018. The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report. Eur J Surg Oncol 44, 436–443. https://doi.org/10.1016/j.ejso.2018.01.010

 

Arkenau, H.-T., Italiano, A., Mak, G., Toulmonde, M., Baird, R.D., Garcia-Corbacho, J., Plummer, R., Flynn, M., Forster, M., Wilson, R.H., Tosi, D., Adenis, A., Donaldson, K., Posner, J., Kawabata, I., Arimura, A., Deva, S., Spicer, J., 2018. An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours. Eur. J. Cancer 103, 17–23. https://doi.org/10.1016/j.ejca.2018.07.134

 

Azria, D., Brengues, M., Gourgou, S., Bourgier, C., 2018a. Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator. Front Oncol 8, 83. https://doi.org/10.3389/fonc.2018.00083

 

Azria, D., Gourgou, S., Brengues, M., Bourgier, C., Ozsahin, M., 2018b. In Regard to Pereira et al. Int. J. Radiat. Oncol. Biol. Phys. 101, 490–491. https://doi.org/10.1016/j.ijrobp.2018.02.021

Barbieri, A., Tami, M., Bry, X., Azria, D., Gourgou, S., Bascoul-Mollevi, C., Lavergne, C., 2018. EM algorithm estimation of a structural equation model for the longitudinal study of the quality of life. Stat Med 37, 1031–1046. https://doi.org/10.1002/sim.7557

 

Bascoul-Mollevi, C., Savina, M., Anota, A., Barbieri, A., Azria, D., Bonnetain, F., Gourgou, S., 2018. Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD. Comput Methods Programs Biomed 158, 153–159. https://doi.org/10.1016/j.cmpb.2018.02.010

 

Belkacemi, Y., Colson-Durand, L., Fayolle-Campana, M., Pons, P., Rialland, A., Bastuji-Garin, S., Hoang, Q.N., Lerouge, D., Jaffré, F., Bollet, M., Azria, D., 2018. A “Wake-Up Call” For Routine Morbidity And Mortality Review Meetings Procedure As Part Of A Quality Governance Program In Radiotherapy Departments: Results Of The Proust Survey. Pract Radiat Oncol. https://doi.org/10.1016/j.prro.2018.09.004

 

Benavides, J.A., Shiva, C., Virhuez, M., Tello, C., Appelgren, A., Vendrell, J., Solassol, J., Godreuil, S., Streicker, D.G., 2018. Extended-spectrum beta-lactamase-producing Escherichia coli in common vampire bats Desmodus rotundus and livestock in Peru. Zoonoses Public Health 65, 454–458. https://doi.org/10.1111/zph.12456

 

Bennouna, J., Hiret, S., Bertaut, A., Bouché, O., Deplanque, G., Borel, C., François, E., Conroy, T., Ghiringhelli, F., des Guetz, G., Seitz, J.-F., Artru, P., Hebbar, M., Stanbury, T., Denis, M.G., Adenis, A., Borg, C., 2018. Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2018.4465

 

Bertoli, S., Picard, M., Bérard, E., Griessinger, E., Larrue, C., Mouchel, P.L., Vergez, F., Tavitian, S., Yon, E., Ruiz, J., Delabesse, E., Luquet, I., Linares, L.K., Saland, E., Carroll, M., Danet-Desnoyers, G., Sarry, A., Huguet, F., Sarry, J.E., Récher, C., 2018. Dexamethasone in hyperleukocytic acute myeloid leukemia. Haematologica 103, 988–998. https://doi.org/10.3324/haematol.2017.184267

 

Beziaud, L., Boullerot, L., Tran, T., Mansi, L., Marie-Joseph, E.L., Ravel, P., Johannes, L., Bayry, J., Tartour, E., Adotévi, O., 2018. Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy. Int. J. Cancer. https://doi.org/10.1002/ijc.31842

 

Bhardwaj, D., Náger, M., Visa, A., Sallán, M.C., Coopman, P.J., Cantí, C., Herreros, J., 2018. Phosphorylated Tyr142 β-catenin localizes to centrosomes and is regulated by Syk. J. Cell. Biochem. 119, 3632–3640. https://doi.org/10.1002/jcb.26571

 

Blomme, A., Van Simaeys, G., Doumont, G., Costanza, B., Bellier, J., Otaka, Y., Sherer, F., Lovinfosse, P., Boutry, S., Palacios, A.P., De Pauw, E., Hirano, T., Yokobori, T., Hustinx, R., Bellahcène, A., Delvenne, P., Detry, O., Goldman, S., Nishiyama, M., Castronovo, V., Turtoi, A., 2018. Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases. Oncogene 37, 1237–1250. https://doi.org/10.1038/s41388-017-0018-x

 

Boogerd, L.S.F., Hoogstins, C.E.S., Schaap, D.P., Kusters, M., Handgraaf, H.J.M., van der Valk, M.J.M., Hilling, D.E., Holman, F.A., Peeters, K.C.M.J., Mieog, J.S.D., van de Velde, C.J.H., Farina-Sarasqueta, A., van Lijnschoten, I., Framery, B., Pèlegrin, A., Gutowski, M., Nienhuijs, S.W., de Hingh, I.H.J.T., Nieuwenhuijzen, G.A.P., Rutten, H.J.T., Cailler, F., Burggraaf, J., Vahrmeijer, A.L., 2018. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. Lancet Gastroenterol Hepatol 3, 181–191. https://doi.org/10.1016/S2468-1253(17)30395-3

 

Bourgier, C., Lemanski, C., Fenoglietto, P., Azria, D., 2018. [The major debate: Micrometastases and breast cancer - To be for nodal irradiation]. Cancer Radiother. https://doi.org/10.1016/j.canrad.2018.07.129

 

Bourgier, Céline, Castan, F., Riou, O., Nguyen, T.-D., Peignaux, K., Lemanski, C., Lagrange, J.-L., Kirova, Y., Lartigau, E., Belkacemi, Y., Rivera, S., Noël, G., Clippe, S., Mornex, F., Hennequin, C., Gourgou, S., Brengues, M., Fenoglietto, P., Ozsahin, E.M., Azria, D., 2018. Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial. Oncotarget 9, 15757–15765. https://doi.org/10.18632/oncotarget.24606

 

Bryden, F., Martin, C., Letast, S., Lles, E., Viéitez-Villemin, I., Rousseau, A., Colas, C., Brachet-Botineau, M., Allard-Vannier, E., Larbouret, C., Viaud-Massuard, M.-C., Joubert, N., 2018. Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates. Org. Biomol. Chem. 16, 1882–1889. https://doi.org/10.1039/c7ob02780j

 

Cabel, L., Carton, M., Cheaib, B., Pierga, J.-Y., Dalenc, F., Mailliez, A., Levy, C., Jacot, W., Debled, M., Leheurteur, M., Desmoulins, I., Lefeuvre, C., Gonçalves, A., Uwer, L., Ferrero, J.-M., Eymard, J.-C., Petit, T., Mouret-Reynier, M.-A., Perrocheau, G., Piot, I., Pérol, D., Simon, G., Lerebours, F., 2018. Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens. Breast Cancer Res. Treat. https://doi.org/10.1007/s10549-018-5017-2

 

Caucheteur, D., Robin, G., Parez, V., Martineau, P., 2018a. Construction of Synthetic Antibody Libraries. Methods Mol. Biol. 1827, 93–108. https://doi.org/10.1007/978-1-4939-8648-4_5

 

Chiba, A., Raman, R., Thomas, A., Lamy, P.-J., Viala, M., Pouderoux, S., Mott, S.L., Schroeder, M.C., Thezenas, S., Jacot, W., 2018. Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer. Clin. Breast Cancer 18, 144–149. https://doi.org/10.1016/j.clbc.2017.12.001

 

Cohen, R., Hain, E., Buhard, O., Guilloux, A., Bardier, A., Kaci, R., Bertheau, P., Renaud, F., Bibeau, F., Fléjou, J.-F., André, T., Svrcek, M., Duval, A., 2018. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2018.4942

 

Conroy, T., Hammel, P., Hebbar, M., Ben Abdelghani, M., Wei, A.C., Raoul, J.-L., Choné, L., Francois, E., Artru, P., Biagi, J.J., Lecomte, T., Assenat, E., Faroux, R., Ychou, M., Volet, J., Sauvanet, A., Breysacher, G., Di Fiore, F., Cripps, C., Kavan, P., Texereau, P., Bouhier-Leporrier, K., Khemissa-Akouz, F., Legoux, J.-L., Juzyna, B., Gourgou, S., O’Callaghan, C.J., Jouffroy-Zeller, C., Rat, P., Malka, D., Castan, F., Bachet, J.-B., Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group, 2018. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N. Engl. J. Med. 379, 2395–2406. https://doi.org/10.1056/NEJMoa1809775

 

Corines, M.J., Nougaret, S., Weiser, M.R., Khan, M., Gollub, M.J., 2018. Gadolinium-Based Contrast Agent During Pelvic MRI: Contribution to Patient Management in Rectal Cancer. Dis. Colon Rectum 61, 193–201. https://doi.org/10.1097/DCR.0000000000000925

 

Costanza, B., Turtoi, A., Bellahcène, A., Hirano, T., Peulen, O., Blomme, A., Hennequière, V., Mutijima, E., Boniver, J., Meuwis, M.-A., Josse, C., Koopmansch, B., Segers, K., Yokobori, T., Fahmy, K., Thiry, M., Coimbra, C., Garbacki, N., Colige, A., Baiwir, D., Bours, V., Louis, E., Detry, O., Delvenne, P., Nishiyama, M., Castronovo, V., 2018. Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget 9, 10665–10680. https://doi.org/10.18632/oncotarget.24366

 

Cottu, P., D’Hondt, V., Dureau, S., Lerebours, F., Desmoulins, I., Heudel, P.-E., Duhoux, F.P., Levy, C., Mouret-Reynier, M.-A., Dalenc, F., Frenel, J.-S., Jouannaud, C., Venat-Bouvet, L., Nguyen, S., Ferrero, J.-M., Canon, J.-L., Grenier, J., Callens, C., Gentien, D., Lemonnier, J., Vincent-Salomon, A., Delaloge, S., 2018. Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer. Ann. Oncol. https://doi.org/10.1093/annonc/mdy448

 

Darlix, A., Griguolo, G., Thezenas, S., Kantelhardt, E., Thomssen, C., Dieci, M.V., Miglietta, F., Conte, P., Braccini, A.L., Ferrero, J.M., Bailleux, C., Jacot, W., Guarneri, V., 2018. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer. J. Neurooncol. 138, 369–382. https://doi.org/10.1007/s11060-018-2805-9

 

de Meric de Bellefon, M., Lemanski, C., Ducteil, A., Fenoglietto, P., Azria, D., Bourgier, C., 2018. Management of the Axilla in the Era of Breast Cancer Heterogeneity. Front Oncol 8, 84. https://doi.org/10.3389/fonc.2018.00084

 

Decraene, C., Silveira, A.B., Bidard, F.-C., Vallée, A., Michel, M., Melaabi, S., Vincent-Salomon, A., Saliou, A., Houy, A., Milder, M., Lantz, O., Ychou, M., Denis, M.G., Pierga, J.-Y., Stern, M.-H., Proudhon, C., 2018. Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR. Clin. Chem. 64, 317–328. https://doi.org/10.1373/clinchem.2017.272518

 

Delhorme, J.-B., Severac, F., Averous, G., Glehen, O., Passot, G., Bakrin, N., Marchal, F., Pocard, M., Lo Dico, R., Eveno, C., Carrere, S., Sgarbura, O., Quenet, F., Ferron, G., Goéré, D., Brigand, C., French National Network of Peritoneal Surface Malignancies (RENAPE), 2018a. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Br J Surg 105, 668–676. https://doi.org/10.1002/bjs.10716

 

Deshayes, E., de Forges, H., Fraisse, J., Eberlé, M.-C., Guillemard, S., Fallières, A., Pouget, J.-P., Tétreau, R., Kotzki, P.-O., Santoro, L., Senesse, P., Flori, N., 2018a. Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC Study. Clin Nutr. https://doi.org/10.1016/j.clnu.2018.08.033

 

Deshayes, E., Ladjohounlou, R., Le Fur, P., Pichard, A., Lozza, C., Boudousq, V., Sevestre, S., Jarlier, M., Kashani, R., Koch, J., Sosabowski, J., Foster, J., Chouin, N., Bruchertseifer, F., Morgenstern, A., Kotzki, P.-O., Navarro-Teulon, I., Pouget, J.-P., 2018b. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer. J. Nucl. Med. 59, 1234–1242. https://doi.org/10.2967/jnumed.118.208611

 

Didier, R., Mallavialle, A., Ben Jouira, R., Domdom, M.A., Tichet, M., Auberger, P., Luciano, F., Ohanna, M., Tartare-Deckert, S., Deckert, M., 2018. Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies. Mol. Cancer Ther. 17, 1416–1429. https://doi.org/10.1158/1535-7163.MCT-17-0919

 

Durand, M., Dubois, F., Dejou, C., Durand, E., Danger, R., Chesneau, M., Brosseau, C., Guerif, P., Soulillou, J.-P., Degauque, N., Eliaou, J.-F., Giral, M., Bonnefoy, N., Brouard, S., 2018. Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance. Kidney Int. 93, 1154–1164. https://doi.org/10.1016/j.kint.2017.12.004

 

Escal, L., Nougaret, S., Guiu, B., Bertrand, M.M., de Forges, H., Tetreau, R., Thézenas, S., Rouanet, P., 2018. MRI-based score to predict surgical difficulty in patients with rectal cancer. Br J Surg 105, 140–146. https://doi.org/10.1002/bjs.10642

 

Escayola, C., Torrent, J.J., Ferron, G., Quenet, F., Querleu, D., 2018. When and Who Should Perform Epithelial Ovarian Cancer Surgery? Int. J. Gynecol. Cancer 28, 594–599. https://doi.org/10.1097/IGC.0000000000001188

 

Fargeas, A., Acosta, O., Ospina Arrango, J.D., Ferhat, A., Costet, N., Albera, L., Azria, D., Fenoglietto, P., Créhange, G., Beckendorf, V., Hatt, M., Kachenoura, A., de Crevoisier, R., 2018. Independent component analysis for rectal bleeding prediction following prostate cancer radiotherapy. Radiother Oncol 126, 263–269. https://doi.org/10.1016/j.radonc.2017.11.011

 

Fiteni, F., Favier, M., Bascoul-Mollevi, C., Gourgou, S., Cousin, C., Houédé, N., 2018. [Impacts of routine patient-reported-outcomes monitoring in oncology]. Bull Cancer 105, 847–848. https://doi.org/10.1016/j.bulcan.2018.06.010

 

Fiteni, F., Paillard, M.-J., Orillard, E., Lefebvre, L., Nadjafizadeh, S., Selmani, Z., Benhamida, S., Roland, A., Baumann, A., Vienot, A., Houédé, N., Pivot, X., 2018b. Enterocolitis in Patients with Cancer Treated with Docetaxel. Anticancer Res. 38, 2443–2446. https://doi.org/10.21873/anticanres.12497

 

Forest, E., Logeay, R., Géminard, C., Kantar, D., Frayssinoux, F., Heron-Milhavet, L., Djiane, A., 2018. The apical scaffold big bang binds to spectrins and regulates the growth of Drosophila melanogaster wing discs. J. Cell Biol. 217, 1047–1062. https://doi.org/10.1083/jcb.201705107

 

Gobbini, E., Ezzalfani, M., Dieras, V., Bachelot, T., Brain, E., Debled, M., Jacot, W., Mouret-Reynier, M.A., Goncalves, A., Dalenc, F., Patsouris, A., Ferrero, J.M., Levy, C., Lorgis, V., Vanlemmens, L., Lefeuvre-Plesse, C., Mathoulin-Pelissier, S., Petit, T., Uwer, L., Jouannaud, C., Leheurteur, M., Lacroix-Triki, M., Cleaud, A.L., Robain, M., Courtinard, C., Cailliot, C., Perol, D., Delaloge, S., 2018. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. Eur. J. Cancer 96, 17–24. https://doi.org/10.1016/j.ejca.2018.03.015

 

Godreuil, S., Marcy, O., Wobudeya, E., Bonnet, M., Solassol, J., 2018. Tackling mortality due to childhood tuberculosis. Lancet Public Health 3, e165. https://doi.org/10.1016/S2468-2667(18)30049-5

 

Gollub, M.J., Arya, S., Beets-Tan, R.G., dePrisco, G., Gonen, M., Jhaveri, K., Kassam, Z., Kaur, H., Kim, D., Knezevic, A., Korngold, E., Lall, C., Lalwani, N., Blair Macdonald, D., Moreno, C., Nougaret, S., Pickhardt, P., Sheedy, S., Harisinghani, M., 2018. Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017. Abdom Radiol (NY) 43, 2893–2902. https://doi.org/10.1007/s00261-018-1642-9

 

Griguolo, G., Jacot, W., Kantelhardt, E., Dieci, M.V., Bourgier, C., Thomssen, C., Bailleux, C., Miglietta, F., Braccini, A.-L., Conte, P., Ferrero, J.M., Guarneri, V., Darlix, A., 2018a. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience. Breast 37, 36–41. https://doi.org/10.1016/j.breast.2017.10.006

 

Griguolo, G., Pouderoux, S., Dieci, M.V., Jacot, W., Bourgier, C., Miglietta, F., Firmin, N., Conte, P., Viala, M., Guarneri, V., Darlix, A., 2018b. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology. Oncologist. https://doi.org/10.1634/theoncologist.2018-0200

 

Griguolo, G., Pouderoux, S., Dieci, M.V., Jacot, W., Bourgier, C., Miglietta, F., Firmin, N., Conte, P., Viala, M., Guarneri, V., Darlix, A., 2018b. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology. Oncologist 23, 1289–1299. https://doi.org/10.1634/theoncologist.2018-0200

 

Grimaldi, M., Boulahtouf, A., Prévostel, C., Thierry, A., Balaguer, P., Blache, P., 2018. A Cell Model Suitable for a High-Throughput Screening of Inhibitors of the Wnt/β-Catenin Pathway. Front Pharmacol 9, 1160. https://doi.org/10.3389/fphar.2018.01160

 

Guerin, M., Gonçalves, A., Toiron, Y., Baudelet, E., Pophillat, M., Granjeaud, S., Fourquet, P., Jacot, W., Tarpin, C., Sabatier, R., Agavnian, E., Finetti, P., Adelaide, J., Birnbaum, D., Ginestier, C., Charafe-Jauffret, E., Viens, P., Bertucci, F., Borg, J.-P., Camoin, L., 2018. Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer. Oncotarget 9, 33762–33777. https://doi.org/10.18632/oncotarget.26031

 

Guiu, S., Mollevi, C., Charon-Barra, C., Boissière, F., Crapez, E., Chartron, E., Lamy, P.-J., Gutowski, M., Bourgier, C., Romieu, G., Simony-Lafontaine, J., Jacot, W., 2018. Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers. Br. J. Cancer. https://doi.org/10.1038/s41416-018-0142-6

 

Hamann, H.A., Pujol, J.-L., 2018. Introduction to the Special Section: The Experience and Impact of Lung Cancer Stigma. J Thorac Oncol 13, 1053–1054. https://doi.org/10.1016/j.jtho.2018.06.006

Harrus, D., Déméné, H., Vasquez, E., Boulahtouf, A., Germain, P., Figueira, A.C., Privalsky, M.L., Bourguet, W., le Maire, A., 2018. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential. Thyroid. https://doi.org/10.1089/thy.2017.0551

 

Hoogstins, C.E.S., Boogerd, L.S.F., Sibinga Mulder, B.G., Mieog, J.S.D., Swijnenburg, R.J., van de Velde, C.J.H., Farina Sarasqueta, A., Bonsing, B.A., Framery, B., Pèlegrin, A., Gutowski, M., Cailler, F., Burggraaf, J., Vahrmeijer, A.L., 2018. Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent. Ann. Surg. Oncol. 25, 3350–3357. https://doi.org/10.1245/s10434-018-6655-7

 

Houede, N., Piazza, P.V., Pourquier, P., 2018. LINE-1 as a therapeutic target for castration-resistant prostate cancer. Front Biosci (Landmark Ed) 23, 1292–1309.

Houvenaeghel, G., de Nonneville, A., Cohen, M., Classe, J.-M., Reyal, F., Mazouni, C., Chopin, N., Martinez, A., Daraï, E., Coutant, C., Colombo, P.-E., Gimbergues, P., Chauvet, M.-P., Azuar, A.-S., Rouzier, R., de Lara, C.T., Muracciole, X., Agostini, A., Gonçalves, A., Lambaudie, E., 2018. Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact. Breast Cancer Res. Treat. https://doi.org/10.1007/s10549-018-4944-2

 

Hutt, E., Da Silva, A., Bogart, E., Le Lay-Diomande, S., Pannier, D., Delaine-Clisant, S., Le Deley, M.-C., Adenis, A., 2018. Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trial. BMJ Open 8, e015904. https://doi.org/10.1136/bmjopen-2017-015904

 

Idoux-Gillet, Y., Nassour, M., Lakis, E., Bonini, F., Theillet, C., Du Manoir, S., Savagner, P., 2018. Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma. Oncogene 37, 578–588. https://doi.org/10.1038/onc.2017.355

 

Italiano, A., Touati, N., Litière, S., Collin, F., Pourquier, P., Gronchi, A., 2018. Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial. Cancer Med 7, 1575–1577. https://doi.org/10.1002/cam4.1403

 

Jacqueline, C., Bonnefoy, N., Charrière, G.M., Thomas, F., Roche, B., 2018. Personal history of infections and immunotherapy: Unexpected links and possible therapeutic opportunities. Oncoimmunology 7, e1466019. https://doi.org/10.1080/2162402X.2018.1466019

 

Jacquet, E., Lardy-Cléaud, A., Pistilli, B., Franck, S., Cottu, P., Delaloge, S., Debled, M., Vanlemmens, L., Leheurteur, M., Guizard, A.V., Laborde, L., Uwer, L., Jacot, W., Berchery, D., Desmoulins, I., Ferrero, J.M., Perrocheau, G., Courtinard, C., Brain, E., Chabaud, S., Robain, M., Bachelot, T., 2018. Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients. Eur. J. Cancer 95, 93–101. https://doi.org/10.1016/j.ejca.2018.03.013

 

Jeannin, O., Reinheimer, E.W., Foury-Leylekian, P., Pouget, J.-P., Auban-Senzier, P., Trzop, E., Collet, E., Fourmigué, M., 2018. Decoupling anion-ordering and spin-Peierls transitions in a strongly one-dimensional organic conductor with a chessboard structure, (o-Me2TTF)2NO3. IUCrJ 5, 361–372. https://doi.org/10.1107/S2052252518004967

 

Jeitany, M., Leroy, C., Tosti, P., Lafitte, M., Le Guet, J., Simon, V., Bonenfant, D., Robert, B., Grillet, F., Mollevi, C., El Messaoudi, S., Otandault, A., Canterel-Thouennon, L., Busson, M., Thierry, A.R., Martineau, P., Pannequin, J., Roche, S., Sirvent, A., 2018. Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. EMBO Mol Med 10. https://doi.org/10.15252/emmm.201707918

 

Jose, C., Hebert-Chatelain, E., Dias Amoedo, N., Roche, E., Obre, E., Lacombe, D., Rezvani, H.R., Pourquier, P., Nouette-Gaulain, K., Rossignol, R., 2018. Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Redox Biol 18, 33–42. https://doi.org/10.1016/j.redox.2018.05.014

 

Juan, T., Géminard, C., Coutelis, J.-B., Cerezo, D., Polès, S., Noselli, S., Fürthauer, M., 2018a. Myosin1D is an evolutionarily conserved regulator of animal left-right asymmetry. Nat Commun 9, 1942. https://doi.org/10.1038/s41467-018-04284-8

 

Kalfa, N., Gaspari, L., Ollivier, M., Philibert, P., Bergougnoux, A., Paris, F., Sultan, C., 2018. Molecular genetics of hypospadias and cryptorchidism recent developments. Clin. Genet. https://doi.org/10.1111/cge.13432

 

Kammerer, E., Fenoglietto, P., Bourgier, C., 2018. [Modalities and advantages of image guided radiation therapy of breast cancer in adjuvant setting]. Cancer Radiother. https://doi.org/10.1016/j.canrad.2018.07.126

 

Kappos, L., Bar-Or, A., Cree, B.A.C., Fox, R.J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D.L., Arnould, S., Scherz, T., Wolf, C., Wallström, E., Dahlke, F., EXPAND Clinical Investigators, 2018. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet 391, 1263–1273. https://doi.org/10.1016/S0140-6736(18)30475-6

 

Khier, S., Lohan, L., 2018. Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature. Future Sci OA 4, FSO295. https://doi.org/10.4155/fsoa-2017-0140

 

Kubik-Huch, R.A., Weston, M., Nougaret, S., Leonhardt, H., Thomassin-Naggara, I., Horta, M., Cunha, T.M., Maciel, C., Rockall, A., Forstner, R., 2018. European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas. Eur Radiol 28, 3125–3137. https://doi.org/10.1007/s00330-017-5157-5

Kumbhar, R., Vidal-Eychenié, S., Kontopoulos, D.-G., Larroque, M., Larroque, C., Basbous, J., Kossida, S., Ribeyre, C., Constantinou, A., 2018. Recruitment of ubiquitin-activating enzyme UBA1 to DNA by poly(ADP-ribose) promotes ATR signalling. Life Sci Alliance 1, e201800096. https://doi.org/10.26508/lsa.201800096

 

Lamy, P.-J., Brouillet, J.-P., Bermont, L., Fouillet, G., Loric, S., 2018. Relevance of total PSA and free PSA prescriptions. Ann. Biol. Clin. (Paris) 76, 659–663. https://doi.org/10.1684/abc.2018.1392

 

Lauche, O., Castan, F., de Forges, H., Guillaumon, C., Gourgou, S., Fenoglietto, P., Aillères, N., Azria, D., Riou, O., 2018. Prospective medical analysis of radiation therapist image repositioning during image-guided radiotherapy. Cancer Radiother 22, 25–30. https://doi.org/10.1016/j.canrad.2017.07.048

 

Lebreton, G., Géminard, C., Lapraz, F., Pyrpassopoulos, S., Cerezo, D., Spéder, P., Ostap, E.M., Noselli, S., 2018a. Molecular to organismal chirality is induced by the conserved myosin 1D. Science 362, 949–952. https://doi.org/10.1126/science.aat8642

 

Lemaitre, F., Goirand, F., Launay, M., Chatelut, E., Boyer, J.-C., Evrard, A., Paludetto, M.-N., Guilhaumou, R., Ciccolini, J., Schmitt, A., 2018. [5-fluorouracil therapeutic drug monitoring: Update and recommendations of the STP-PT group of the SFPT and the GPCO-Unicancer]. Bull Cancer. https://doi.org/10.1016/j.bulcan.2018.06.008

 

Leusch, F.D.L., Neale, P.A., Arnal, C., Aneck-Hahn, N.H., Balaguer, P., Bruchet, A., Escher, B.I., Esperanza, M., Grimaldi, M., Leroy, G., Scheurer, M., Schlichting, R., Schriks, M., Hebert, A., 2018. Analysis of endocrine activity in drinking water, surface water and treated wastewater from six countries. Water Res. 139, 10–18. https://doi.org/10.1016/j.watres.2018.03.056

 

Liu, Y., Yonemura, Y., Levine, E.A., Glehen, O., Goere, D., Elias, D., Morris, D.L., Sugarbaker, P.H., Tuech, J.J., Cashin, P., Spiliotis, J.D., de Hingh, I., Ceelen, W., Baumgartner, J.M., Piso, P., Katayama, K., Deraco, M., Kusamura, S., Pocard, M., Quenet, F., Fushita, S., BIG-RENAPE Group, 2018. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience. Ann. Surg. Oncol. 25, 1184–1192. https://doi.org/10.1245/s10434-018-6369-x

 

Loriot, M.-A., Ciccolini, J., Thomas, F., Barin-Le-Guellec, C., Royer, B., Milano, G., Picard, N., Becquemont, L., Verstuyft, C., Narjoz, C., Schmitt, A., Bobin-Dubigeon, C., Harle, A., Paci, A., Poinsignon, V., Quaranta, S., Evrard, A., Hennart, B., Broly, F., Fonrose, X., Lafay-Chebassier, C., Wozny, A.-S., Masskouri, F., Boyer, J.-C., Etienne-Grimaldi, M.-C., 2018. [Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks]. Bull Cancer 105, 397–407. https://doi.org/10.1016/j.bulcan.2018.02.001

 

Marcos, E., Nougaret, S., Tsujimoto, S., Genovesio, A., 2018. Outcome Modulation Across Tasks in the Primate Dorsolateral Prefrontal Cortex. Neuroscience 371, 96–105. https://doi.org/10.1016/j.neuroscience.2017.11.019

 

Mariette, C., Renaud, F., Piessen, G., Gele, P., Copin, M.-C., Leteurtre, E., Delaeter, C., Dib, M., Clisant, S., Harter, V., Bonnetain, F., Duhamel, A., Christophe, V., Adenis, A., Fregat Working Group, 2018. The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers. BMC Cancer 18, 139. https://doi.org/10.1186/s12885-018-3991-8

 

Martin, C., Kizlik-Masson, C., Pèlegrin, A., Watier, H., Viaud-Massuard, M.-C., Joubert, N., 2018. Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27-28, 2017, Tours, France. MAbs 10, 210–221. https://doi.org/10.1080/19420862.2017.1412130

 

Martinez, A., Filleron, T., Rouanet, P., Méeus, P., Lambaudie, E., Classe, J.M., Foucher, F., Narducci, F., Gouy, S., Guyon, F., Marchal, F., Jouve, E., Colombo, P.E., Mourregot, A., Rivoire, M., Chopin, N., Houvenaeghel, G., Jaffre, I., Leveque, J., Lavoue, V., Leblanc, E., Morice, P., Stoeckle, E., Verheaghe, J.L., Querleu, D., Ferron, G., 2018. Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study. Ann. Surg. Oncol. 25, 535–541. https://doi.org/10.1245/s10434-017-6120-z

 

Mazard, T., Boonsirikamchai, P., Overman, M.J., Asran, M.A., Choi, H., Herron, D., Eng, C., Maru, D.M., Ychou, M., Vauthey, J.-N., Loyer, E.M., Kopetz, S., 2018. Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Gut 67, 1095–1102. https://doi.org/10.1136/gutjnl-2017-313786

 

Mbatchi, L.C., Brouillet, J.-P., Evrard, A., 2018. Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability. Pharmacogenomics 19, 61–77. https://doi.org/10.2217/pgs-2017-0121

 

McMahon, S.J., Paganetti, H., Prise, K.M., 2018. LET-weighted doses effectively reduce biological variability in proton radiotherapy planning. Phys Med Biol 63, 225009. https://doi.org/10.1088/1361-6560/aae8a5

 

Mehta, S., Schwarz, L., Spiliotis, J., Hsieh, M.-C., Akaishi, E.H., Goere, D., Sugarbaker, P.H., Baratti, D., Quenet, F., Bartlett, D.L., Villeneuve, L., Kepenekian, V., PSOGI and BIG-RENAPE Working Groups, 2018. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2018.05.021

 

Mercier, F., Bakrin, N., Bartlett, D.L., Goere, D., Quenet, F., Dumont, F., Heyd, B., Abboud, K., Marolho, C., Villeneuve, L., Glehen, O., PSOGI Working Group, BIG-RENAPE Working Group, 2018. Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE. Ann. Surg. Oncol. 25, 1668–1675. https://doi.org/10.1245/s10434-018-6464-z

 

Mestre-Francés, N., Serratrice, N., Gennetier, A., Devau, G., Cobo, S., Trouche, S.G., Fontès, P., Zussy, C., De Deurwaerdere, P., Salinas, S., Mennechet, F.J., Dusonchet, J., Schneider, B.L., Saggio, I., Kalatzis, V., Luquin-Piudo, M.R., Verdier, J.-M., Kremer, E.J., 2018. Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate. JCI Insight 3. https://doi.org/10.1172/jci.insight.98202

 

Montagner, A., Le Cam, L., Guillou, H., 2018a. β-catenin oncogenic activation rewires fatty acid catabolism to fuel hepatocellular carcinoma. Gut. https://doi.org/10.1136/gutjnl-2018-316557

 

Morel, S., Arnould, S., Vitou, M., Boudard, F., Guzman, C., Poucheret, P., Fons, F., Rapior, S., 2018. Antiproliferative and Antioxidant Activities of Wild Boletales Mushrooms from France. Int J Med Mushrooms 20, 13–29. https://doi.org/10.1615/IntJMedMushrooms.2018025329

 

Neiveyans, M., Melhem, R., Arnoult, C., Bourquard, T., Jarlier, M., Busson, M., Laroche, A., Cerutti, M., Pugnières, M., Ternant, D., Gaborit, N., Chardès, T., Poupon, A., Gouilleux-Gruart, V., Pèlegrin, A., Poul, M.-A., 2019. A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions. MAbs. https://doi.org/10.1080/19420862.2018.1564510

 

Nougaret, S., Tardieu, M., Vargas, H.A., Reinhold, C., Vande Perre, S., Bonanno, N., Sala, E., Thomassin-Naggara, I., 2018. Ovarian cancer: An update on imaging in the era of radiomics. Diagn Interv Imaging. https://doi.org/10.1016/j.diii.2018.11.007

 

Nougaret, Stephanie, Horta, M., Sala, E., Lakhman, Y., Thomassin-Naggara, I., Kido, A., Masselli, G., Bharwani, N., Sadowski, E., Ertmer, A., Otero-Garcia, M., Kubik-Huch, R.A., Cunha, T.M., Rockall, A., Forstner, R., 2018a. Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology. Eur Radiol. https://doi.org/10.1007/s00330-018-5515-y

 

Nougaret, Stephanie, Lakhman, Y., Molinari, N., Feier, D., Scelzo, C., Vargas, H.A., Sosa, R.E., Hricak, H., Soslow, R.A., Grisham, R.N., Sala, E., 2018b. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. AJR Am J Roentgenol 210, 918–926. https://doi.org/10.2214/AJR.17.18254

 

Ogier, C., Colombo, P.-E., Bousquet, C., Canterel-Thouennon, L., Sicard, P., Garambois, V., Thomas, G., Gaborit, N., Jarlier, M., Pirot, N., Pugnière, M., Vie, N., Gongora, C., Martineau, P., Robert, B., Pèlegrin, A., Chardès, T., Larbouret, C., 2018. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Lett. 432, 227–236. https://doi.org/10.1016/j.canlet.2018.06.023

 

 

Ollivier, M., Paris, F., Philibert, P., Garnier, S., Coffy, A., Fauconnet-Servant, N., Haddad, M., Guys, J.M., Reynaud, R., Faure, A., Merrot, T., Wagner, K., Bréaud, J., Valla, J.S., Dobremez, E., Gaspari, L., Daures, J.-P., Sultan, C., Kalfa, N., 2018. Family History is Underestimated in Children with Isolated Hypospadias: A French Multicenter Report of 88 Families. J. Urol. 200, 890–894. https://doi.org/10.1016/j.juro.2018.04.072

 

Ousmen, A., Touraine, C., Deliu, N., Cottone, F., Bonnetain, F., Efficace, F., Brédart, A., Mollevi, C., Anota, A., 2018. Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review. Health Qual Life Outcomes 16, 228. https://doi.org/10.1186/s12955-018-1055-z

 

Overman, M.J., Ferrarotto, R., Raghav, K., George, B., Qiao, W., Machado, K.K., Saltz, L.B., Mazard, T., Vauthey, J.N., Hoff, P.M., Hobbs, B., Loyer, E.M., Kopetz, S., 2018. The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia. J. Natl. Cancer Inst. 110, 888–894. https://doi.org/10.1093/jnci/djx288

 

Oza, A.M., Matulonis, U.A., Malander, S., Hudgens, S., Sehouli, J., Del Campo, J.M., Berton-Rigaud, D., Banerjee, S., Scambia, G., Berek, J.S., Lund, B., Tinker, A.V., Hilpert, F., Vázquez, I.P., D’Hondt, V., Benigno, B., Provencher, D., Buscema, J., Agarwal, S., Mirza, M.R., 2018. Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial. Lancet Oncol. 19, 1117–1125. https://doi.org/10.1016/S1470-2045(18)30333-4

 

Pannier, D., Adenis, A., Bogart, E., Dansin, E., Clisant-Delaine, S., Decoupigny, E., Lesoin, A., Amela, E., Ducornet, S., Meurant, J.-P., Le Deley, M.-C., Penel, N., 2018. Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial. BMC Cancer 18, 775. https://doi.org/10.1186/s12885-018-4678-x

 

Park, Y.-Y., Teyssier, C., Vanacker, J.-M., Choi, H.-S., 2018. Retraction Note: Distinct Repressive Properties of the Mammalian and Fish Orphan Nuclear Receptors SHP and DAX-1. Mol. Cells 41, 1081. https://doi.org/10.14348/molcells.2018.3221

 

Péron, J., Mercier, F., Tuech, J.-J., Younan, R., Sideris, L., Gelli, M., Dumont, F., Le Roy, B., Sgarbura, O., Lo Dico, R., Bibeau, F., Glehen, O., Passot, G., on behalf BIG-RENAPE working groups, 2018. The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasis. Surgery. https://doi.org/10.1016/j.surg.2018.07.027

 

Pignot, G., Houédé, N., Roumiguié, M., Audenet, F., Brunelle, S., Colin, P., Compérat, E., Larré, S., Masson-Lecomte, A., Neuzillet, Y., Xylinas, E., Méjean, A., Rouprêt, M., les membres du CCAFU Vessie, 2018. [ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology]. Prog. Urol. https://doi.org/10.1016/j.purol.2018.07.003

 

Piton, N., Ruminy, P., Gravet, C., Marchand, V., Colasse, É., Lamy, A., Naoures Mear, C.L., Bibeau, F., Marguet, F., Guisier, F., Salaün, M., Thiberville, L., Jardin, F., Sabourin, J.-C., 2018. Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma. Lab. Invest. 98, 371–379. https://doi.org/10.1038/labinvest.2017.124

 

Ploquin, A., Pistilli, B., Tresch, E., Frenel, J.S., Lerebours, F., Lesur, A., Loustalot, C., Bachelot, T., Provansal, M., Ferrero, J.M., Coussy, F., Debled, M., Kerbrat, P., Vinceneux, A., Allouache, D., Morvan, F., Dalenc, F., Guiu, S., Rouzier, R., Vanlemmens, L., 2018a. 5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study. Eur. J. Cancer 95, 30–37. https://doi.org/10.1016/j.ejca.2018.02.030

 

Pouget, J.-P., Georgakilas, A.G., Ravanat, J.-L., 2018a. Targeted and Off-Target (Bystander and Abscopal) Effects of Radiation Therapy: Redox Mechanisms and Risk/Benefit Analysis. Antioxid. Redox Signal. 29, 1447–1487. https://doi.org/10.1089/ars.2017.7267

 

Pourquier, P., 2018. [How to manipulate DNA repair to generate neoantigens and ameliorate the efficacy of immunotherapies]. Bull Cancer. https://doi.org/10.1016/j.bulcan.2018.07.004

 

Prunaretty, J., Boisselier, P., Aillères, N., Riou, O., Simeon, S., Bedos, L., Azria, D., Fenoglietto, P., 2019. Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison. Rep Pract Oncol Radiother 24, 97–104. https://doi.org/10.1016/j.rpor.2018.11.003

 

Pujol, J.L., Roch, B., 2018. [Small cell lung cancer and immuno-oncologic agents: End of the cisplatin - etoposide era?]. Rev Mal Respir 35, 846–851. https://doi.org/10.1016/j.rmr.2017.07.026

 

Pujol, Jean-Louis, Jean-Baptiste, S., Bommart, S., Roch, B., 2018a. Synchronous multiple non-small cell lung cancers in an allograft lung recipient. Lung Cancer 124, 291–292. https://doi.org/10.1016/j.lungcan.2018.07.024

 

Pujol, Jean-Louis, Roch, B., Pujol, C.N., Goze, C., 2018b. [Medical treatment of small cell lung cancer: Can we leave the area of cisplatin-etoposide?]. Bull Cancer 105, 955–966. https://doi.org/10.1016/j.bulcan.2018.05.014

 

Pujol, P., Vande Perre, P., Faivre, L., Sanlaville, D., Corsini, C., Baertschi, B., Anahory, M., Vaur, D., Olschwang, S., Soufir, N., Bastide, N., Amar, S., Vintraud, M., Ingster, O., Richard, S., Le Coz, P., Spano, J.-P., Caron, O., Hammel, P., Luporsi, E., Toledano, A., Rebillard, X., Cambon-Thomsen, A., Putois, O., Rey, J.-M., Hervé, C., Zorn, C., Baudry, K., Galibert, V., Gligorov, J., Azria, D., Bressac-de Paillerets, B., Burnichon, N., Spielmann, M., Zarca, D., Coupier, I., Cussenot, O., Gimenez-Roqueplo, A.-P., Giraud, S., Lapointe, A.-S., Niccoli, P., Raingeard, I., Le Bidan, M., Frebourg, T., Rafii, A., Geneviève, D., 2018. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations. Eur. J. Hum. Genet. https://doi.org/10.1038/s41431-018-0224-1

 

Pulido, M., Roubaud, G., Cazeau, A.-L., Mahammedi, H., Vedrine, L., Joly, F., Mourey, L., Pfister, C., Goberna, A., Lortal, B., Bellera, C., Pourquier, P., Houédé, N., 2018. Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer. BMC Cancer 18, 194. https://doi.org/10.1186/s12885-018-4059-5

 

Quénet, F., 2018a. Colorectal peritoneal carcinomatosis: What is the future of HIPEC? Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2018.08.009

 

Quénet, F., Pissas, M.-H., Gil, H., Roca, L., Carrère, S., Sgarbura, O., Rouanet, P., de Forges, H., Khellaf, L., Deshayes, E., Ychou, M., Bibeau, F., 2018. Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival. Surgery. https://doi.org/10.1016/j.surg.2018.10.006

 

Renard, D., Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., Menjot de Champfleur, N., Thouvenot, E., 2018. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation. J. Alzheimers Dis. 61, 1107–1117. https://doi.org/10.3233/JAD-170843

 

Romaniello, D., Mazzeo, L., Mancini, M., Marrocco, I., Noronha, A., Kreitman, M., Srivastava, S., Ghosh, S., Lindzen, M., Salame, T.M., Onn, A., Bar, J., Yarden, Y., 2018. A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways. Clin. Cancer Res. https://doi.org/10.1158/1078-0432.CCR-18-0450

 

Ronca, R., Van Ginderachter, J.A., Turtoi, A., 2018. Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes. Curr Opin Oncol 30, 45–53. https://doi.org/10.1097/CCO.0000000000000420

 

Rouanet, P., Bertrand, M.M., Jarlier, M., Mourregot, A., Traore, D., Taoum, C., de Forges, H., Colombo, P.-E., 2018. Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives. Ann. Surg. Oncol. 25, 3572–3579. https://doi.org/10.1245/s10434-018-6738-5

 

Rouanne, M., Roumiguié, M., Houédé, N., Masson-Lecomte, A., Colin, P., Pignot, G., Larré, S., Xylinas, E., Rouprêt, M., Neuzillet, Y., 2018. Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways. World J Urol. https://doi.org/10.1007/s00345-018-2332-5

 

Sanchez, C., Snyder, M.W., Tanos, R., Shendure, J., Thierry, A.R., 2018. New insights into structural features and optimal detection of circulating tumor DNA determined by single-strand DNA analysis. npj Genomic Medicine 3. https://doi.org/10.1038/s41525-018-0069-0

 

Sanchez-Martinez, D., Allende-Vega, N., Orecchioni, S., Talarico, G., Cornillon, A., Vo, D.-N., Rene, C., Lu, Z.-Y., Krzywinska, E., Anel, A., Galvez, E.M., Pardo, J., Robert, B., Martineau, P., Hicheri, Y., Bertolini, F., Cartron, G., Villalba, M., 2018. Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors. Theranostics 8, 3856–3869. https://doi.org/10.7150/thno.25149

 

Shoaib, M., Walter, D., Gillespie, P.J., Izard, F., Fahrenkrog, B., Lleres, D., Lerdrup, M., Johansen, J.V., Hansen, K., Julien, E., Blow, J.J., Sørensen, C.S., 2018. Histone H4K20 methylation mediated chromatin compaction threshold ensures genome integrity by limiting DNA replication licensing. Nat Commun 9, 3704. https://doi.org/10.1038/s41467-018-06066-8

 

Sixou, S., Müller, K., Jalaguier, S., Kuhn, C., Harbeck, N., Mayr, D., Engel, J., Jeschke, U., Ditsch, N., Cavaillès, V., 2018. Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival. Transl Oncol 11, 1090–1096. https://doi.org/10.1016/j.tranon.2018.06.006

 

Solassol, J., Quantin, X., Larrieux, M., Senal, R., Audran, P., Grand, D., Mangé, A., Diamandis, E.P., Vendrell, J.A., 2018. Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer. Clin. Chem. Lab. Med. 56, e243–e246. https://doi.org/10.1515/cclm-2017-0967

 

Soler, A., Cayrefourcq, L., Mazard, T., Babayan, A., Lamy, P.-J., Assou, S., Assenat, E., Pantel, K., Alix-Panabières, C., 2018. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes. Sci Rep 8, 15931. https://doi.org/10.1038/s41598-018-34365-z

 

Stahl, P., Poinsignon, Y., Pouedras, P., Ciubotaru, V., Berry, L., Emu, B., Krause, P.J., Ben Mamoun, C., Cornillot, E., 2018. Case report of the patient source of the Babesia microti R1 reference strain and implications for travelers. J Travel Med 25. https://doi.org/10.1093/jtm/tax073

 

Stuani, L., Riols, F., Millard, P., Sabatier, M., Batut, A., Saland, E., Viars, F., Tonini, L., Zaghdoudi, S., Linares, L.K., Portais, J.-C., Sarry, J.-E., Bertrand-Michel, J., 2018a. Stable Isotope Labeling Highlights Enhanced Fatty Acid and Lipid Metabolism in Human Acute Myeloid Leukemia. Int J Mol Sci 19. https://doi.org/10.3390/ijms19113325

 

Sultan, C., Gaspari, L., Maimoun, L., Kalfa, N., Paris, F., 2018. Disorders of puberty. Best Pract Res Clin Obstet Gynaecol 48, 62–89. https://doi.org/10.1016/j.bpobgyn.2017.11.004

 

Suzuki, M., Yokobori, T., Gombodorj, N., Yashiro, M., Turtoi, A., Handa, T., Ogata, K., Oyama, T., Shirabe, K., Kuwano, H., 2018. High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer. J Surg Oncol 118, 966–974. https://doi.org/10.1002/jso.25217

 

Taourel, P., Pages, E., Millet, I., Bourgier, C., Rouanet, P., Jacot, W., Crochet, P., Azria, D., 2018a. Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy. Crit. Rev. Oncol. Hematol. 132, 51–65. https://doi.org/10.1016/j.critrevonc.2018.09.012

Tapi Nzali, M.D., Aze, J., Bringay, S., Lavergne, C., Mollevi, C., Optiz, T., 2018. Reconciliation of patient/doctor vocabulary in a structured resource. Health Informatics J 1460458217751014. https://doi.org/10.1177/1460458217751014

 

Thierry, A.R., 2018. A Step Closer to Cancer Screening by Blood Test. Clin. Chem. 64, 1420–1422. https://doi.org/10.1373/clinchem.2018.287847

Tosi, D., Pérez-Gracia, E., Atis, S., Vié, N., Combès, E., Gabanou, M., Larbouret, C., Jarlier, M., Mollevi, C., Torro, A., Del Rio, M., Martineau, P., Gongora, C., 2018. Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment. BMC Cancer 18, 812. https://doi.org/10.1186/s12885-018-4712-z

 

Van Cutsem, E., Martinelli, E., Cascinu, S., Sobrero, A., Banzi, M., Seitz, J.-F., Barone, C., Ychou, M., Peeters, M., Brenner, B., Hofheinz, R.D., Maiello, E., André, T., Spallanzani, A., Garcia-Carbonero, R., Arriaga, Y.E., Verma, U., Grothey, A., Kappeler, C., Miriyala, A., Kalmus, J., Falcone, A., Zaniboni, A., 2018. Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study. Oncologist. https://doi.org/10.1634/theoncologist.2018-0072

 

Vendrell, J.A., Vilquin, P., Larrieux, M., Van Goethem, C., Solassol, J., 2018. Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection. J Mol Diagn 20, 754–764. https://doi.org/10.1016/j.jmoldx.2018.06.003

 

Viala, M., Chiba, A., Thezenas, S., Delmond, L., Lamy, P.-J., Mott, S.L., Schroeder, M.C., Thomas, A., Jacot, W., 2018. Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study. BMC Cancer 18, 770. https://doi.org/10.1186/s12885-018-4686-x

 

Viala, M., Vinches, M., Alexandre, M., Mollevi, C., Durigova, A., Hayaoui, N., Homicsko, K., Cuenant, A., Gongora, C., Gianni, L., Tosi, D., 2018. Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose

Ziach, K., Chollet, C., Parissi, V., Prabhakaran, P., Marchivie, M., Corvaglia, V., Bose, P.P., Laxmi-Reddy, K., Godde, F., Schmitter, J.-M., Chaignepain, S., Pourquier, P., Huc, I., 2018. Single helically folded aromatic oligoamides that mimic the charge surface of double-stranded B-DNA. Nat Chem 10, 511–518. https://doi.org/10.1038/s41557-018-0018-7

 

Zouaz, A., Fernando, C., Perez, Y., Sardet, C., Julien, E., Grimaud, C., 2018. Cell-cycle regulation of non-enzymatic functions of the Drosophila methyltransferase PR-Set7. Nucleic Acids Res. 46, 2834–2849. https://doi.org/10.1093/nar/gky034

 

 

Haut de page

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés